Endoscopes Market Size, Share, Industry, Forecast and outlook (2024-2031)

Report Overview

The Endoscopes Market is expected to grow at a CAGR of 7.1% during the forecast 2024-2031

Endoscopy is a procedure to examine the internal body parts using an instrument called an endoscope. An endoscope is a long, thin, flexible tube that has a light source and camera at one end. Images of the inside body are relayed to a television screen. Endoscopy can be used to investigate unusual symptoms and help perform certain types of surgery. It is also used to remove a small sample of tissue for analysis.

Market Summary

For More Insights Request Free Sample

Market Dynamics

• The increasing prevalence of cancer is boosting the global endoscopy market, as endoscopy procedures, such as laryngoscopy, upper endoscopy, and colonoscopy, are used in the diagnosis of cancer.
• The most common cancers are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer.
• The number of new cases of cancer is 439.2 per 100,000 men and women per year. The number of cancer deaths is 163.5 per 100,000 men and women per year in the U.S.
• According to Cancer Research U.K., there are more than 360,000 new cancer cases in the UK every year, that's nearly 990 every day. The incidence rates for all cancers combined are projected to rise by 2% in the UK between 2014 and 2035, to 742 cases per 100,000 people by 2035. In the UK there were around 183,000 new cancer cases in males and around 177,000 new cancer cases in females, in 2015.

Market Segmentation Analysis

• Based on product type, the global market for endoscopes is broadly segmented as rigid endoscopes, flexible endoscopes, capsule endoscopes, disposable endoscopes, and robot-assisted endoscopes.
• Currently, flexible endoscopes account for a dominant share of the global endoscopes market. The market-driven by flexible endoscopes has a positive impact due to the collaboration between companies to develop new flexible endoscopes.
• For instance, in July 2017, PENTAX collaborated with Shanghai Aohua Photoelectricity Endoscope Co., Ltd., to develop products in the field of flexible medical endoscopy. Moreover, in October 2017, AGA partnered with Apollo Endosurgery to track outcomes of trans-oral endoscopic suturing procedures performed with the company’s OverStitch system. Transoral, flexible endoscopic suturing is used for the treatment of gastroesophageal reflux diseases.
• Increasing regulatory approvals for flexible endoscopes is one of the key factors driving the global endoscopes market. For instance, in May 2016, EndoChoice received FDA 510(k) clearance for its Orca sterile, single-use air, water, and suction valves designed for Olympus 160, 180, and 190 flexible endoscopes, and also introduced its 3rd-gen Fuse endoscopy system and RescueNet retrieval device.
• The robot-assisted endoscopes are showing significant growth in 2018, due to multiple regulatory approvals in recent years. For instance, in March 2018, Auris Health received FDA clearance for its Monarch robotic endoscopy platform. The Monarch system is a flexible robotic endoscopic platform that uses a controller-like interface that allows the operating physicians to navigate the robotic endoscope through the periphery of the lung

Market Geographical Share

• The global Endoscopes market is segmented into North America, Europe, Asia Pacific, South America, the Middle East, and Africa.
• North America is dominating the global Endoscopes market, due to the increasing incidence of cancer in the US. For instance, according to National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer in the United States and 609,640 people will die from the disease.
• The increasing product launches in the US market are driving the North American endoscopes market. For instance, in July 2018, FUJIFILM Medical Systems U.S.A., Inc., introduced its 700 Series Endoscopes.
• Europe is the second largest market for endoscopes in 2018, due to the investment in Endoscopy Action Plan, by the regulatory body. For instance, in March 2019, the Scottish Government introduced Endoscopy Action Plan and invested £6 million.
• The Endoscopy Action Plan is for patients with suspected cancer, with the investment the government will provide new technologies, additional clinics, and additional staff training.
• Waiting times for patients with suspected cancer will be targeted in this action plan, which will introduce new technologies, additional clinics, and additional staff training.
• The launch of the new endoscope in Europe is also driving the endoscopes market in the region. For instance, in July 2016, PENTAX Medical introduced a new high-definition (HD) pulmonology endoscopy system in the European markets. The new DEFINA system in Pulmonology combines a state-of-the-art HD processor with i-scan imaging technology and two highly maneuverable HD bronchoscopes.

Market Companies

• The major players include Olympus Corporation, Ethicon US, LLC, Fujifilm Holdings Corporation, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Stryker Corporation, PENTAX Medical, Medtronic, Inc., Richard Wolf GmbH, and Cook Medical.
• Most of the key companies focusing on the R&D of advanced products are aiming for inorganic growth strategies to boost market competitiveness. For instance, in June 2018, PENTAX Medical, a leading company for diagnostic and therapeutic endoscopy solutions, entered into an exclusive distribution agreement with CapsoVision for its CapsoCam Plus Capsule Endoscopy line of products.
• In November 2016, CapsoVision, Inc., received FDA 510(k) clearance for the CapsoCam Plus small bowel capsule endoscope system. CapsoCam Plus is a technology that provides a novel 360º panoramic lateral image of the small bowel, used for the detection of small bowel abnormalities.